6030

CN:HEBANG

四川和邦生物科技股份有限公司

  • Stock

Last Close

2.06

22/11 07:00

Market Cap

13.94B

Beta: -

Volume Today

116.62M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
498.70M
-
725.19M
45.42%
861.24M
18.76%
842.38M
2.19%
963.98M
14.43%
1.06B
10.03%
1.19B
11.96%
975.41M
17.86%
772.74M
20.78%
1.49B
93.35%
3.24B
116.82%
average payables
206.65M
-
533.15M
157.99%
793.53M
48.84%
728.09M
8.25%
684.00M
6.06%
720.12M
5.28%
856.99M
19.01%
1.01B
17.44%
1.10B
9.19%
1.52B
38.02%
1.71B
12.79%
average receivables
916.21M
-
971.11M
5.99%
765.86M
21.14%
918.94M
19.99%
1.31B
42.83%
1.35B
2.95%
1.18B
12.52%
1.57B
33.08%
1.82B
15.47%
2.30B
26.34%
2.49B
8.55%
book value per share
0.54
-
0.74
36.56%
0.83
12.78%
1.32
57.79%
1.27
3.21%
1.21
5.11%
1.30
7.34%
1.31
0.67%
1.69
29.27%
2.20
30.18%
2.25
2.29%
capex per share
-0.10
-
-0.11
13.23%
-0.15
34.43%
-0.09
43.14%
-0.06
30.85%
-0.04
32.06%
-0.08
91.07%
-0.02
69.81%
-0.21
790.08%
-0.11
47.66%
-0.10
11.56%
capex to depreciation
-3.03
-
-2.67
12.06%
-3.50
31.30%
-1.62
53.68%
-0.97
40.34%
-0.63
34.68%
-1.04
64.90%
-0.31
70.59%
-2.69
778.98%
-1.01
62.62%
-0.83
18.01%
capex to operating cash flow
1.47
-
-3.50
338.41%
-2.52
28.14%
-1.18
53.21%
-2.87
144.05%
-0.38
86.60%
-4.07
956.35%
-0.53
86.86%
-0.54
1.58%
-0.35
34.77%
-4.13
1,065.96%
capex to revenue
-0.37
-
-0.33
12.19%
-0.39
20.42%
-0.20
50.46%
-0.11
45.14%
-0.06
43.63%
-0.11
83.45%
-0.04
66.25%
-0.18
369.35%
-0.07
59.17%
-0.09
31.80%
cash per share
0.05
-
0.02
55.26%
0.08
231.51%
0.04
48.51%
0.10
147.97%
0.15
53.08%
0.09
37.58%
0.10
6.53%
0.21
113.81%
0.53
151.90%
0.35
33.33%
days of inventory on hand
154.53
-
190.57
23.32%
134.02
29.68%
119.65
10.72%
109.84
8.20%
82.46
24.93%
104.34
26.53%
54.11
48.14%
58.11
7.40%
101.69
75.00%
233.64
129.75%
days payables outstanding
74.60
-
169.37
127.04%
128.29
24.25%
92.86
27.62%
72.01
22.46%
57.93
19.55%
76.90
32.75%
89.01
15.75%
73.65
17.26%
91.97
24.87%
81.93
10.92%
days sales outstanding
291.24
-
110.79
61.96%
110.71
0.08%
102.21
7.68%
127.54
24.78%
63.60
50.13%
80.54
26.64%
126.92
57.58%
66.73
47.42%
77.99
16.88%
91.54
17.37%
debt to assets
0.35
-
0.36
2.61%
0.32
10.97%
0.10
69.96%
0.07
27.13%
0.09
24.92%
0.13
46.87%
0.15
13.57%
0.08
47.36%
0.08
1.44%
0.09
22.80%
debt to equity
0.59
-
0.69
16.21%
0.57
17.50%
0.12
79.15%
0.08
29.68%
0.11
26.80%
0.17
56.38%
0.19
16.53%
0.10
49.94%
0.10
1.24%
0.12
22.12%
dividend yield
0.04
-
0.02
46.42%
0.02
27.85%
0.01
34.67%
0.01
41.33%
0.02
175.28%
0.01
67.98%
0.01
37.98%
0.00
64.60%
0.01
176.02%
0.02
155.41%
earnings yield
0.01
-
0.07
611.34%
0.01
85.38%
0.02
65.25%
0.03
71.97%
0.02
15.94%
0.04
62.36%
0.00
99.40%
0.11
43,649.93%
0.14
37.00%
0.06
56.62%
enterprise value
8.08B
-
12.57B
55.48%
26.07B
107.36%
19.42B
25.49%
17.59B
9.40%
14.44B
17.96%
14.08B
2.47%
13.41B
4.74%
28.43B
111.98%
23.67B
16.75%
19.78B
16.42%
enterprise value over ebitda
22.57
-
10.80
52.17%
34.65
220.94%
22.61
34.76%
14.50
35.87%
11.86
18.22%
10.84
8.61%
18.25
68.41%
6.61
63.79%
4.29
35.06%
8.16
90.21%
ev to operating cash flow
-19.84
-
61.42
409.55%
58.03
5.52%
33.76
41.82%
99.44
194.54%
15.29
84.63%
86.41
465.33%
36.36
57.92%
8.89
75.54%
8.95
0.65%
98.54
1,000.87%
ev to sales
5.04
-
5.75
14.01%
9.11
58.32%
5.61
38.40%
3.71
33.79%
2.40
35.31%
2.36
1.82%
2.55
8.09%
2.88
13.02%
1.82
37.00%
2.26
24.44%
free cash flow per share
-0.17
-
-0.08
51.87%
-0.09
13.39%
-0.01
85.77%
-0.04
198.89%
0.06
266.45%
-0.06
190.19%
0.02
134.89%
0.17
760.42%
0.20
13.35%
-0.07
136.73%
free cash flow yield
-0.16
-
-0.05
65.27%
-0.03
45.52%
-0.01
81.29%
-0.02
242.66%
0.04
309.87%
-0.04
198.11%
0.01
136.37%
0.05
258.30%
0.06
27.15%
-0.03
147.31%
graham net net
-0.12
-
-0.51
314.17%
-0.40
22.56%
-0.09
78.26%
0.09
203.71%
0.06
30.46%
-0.07
209.36%
-0.11
56.77%
0.03
132.50%
0.39
1,023.07%
0.31
21.24%
graham number
0.36
-
1.32
266.90%
0.77
41.41%
1.09
40.84%
1.31
20.49%
1.04
20.46%
1.32
26.57%
0.10
92.42%
3.69
3,585.32%
4.65
26.09%
2.73
41.31%
income quality
-6.32
-
0.30
104.82%
1.88
517.56%
1.79
4.90%
0.35
80.43%
3.17
804.19%
0.32
89.85%
126.77
39,321.09%
1.05
99.17%
0.69
34.19%
0.16
77.46%
intangibles to total assets
0.14
-
0.23
65.53%
0.22
5.36%
0.20
11.16%
0.20
0.25%
0.19
6.16%
0.21
11.14%
0.20
4.02%
0.22
8.94%
0.17
23.00%
0.07
54.97%
interest coverage
0.85
-
5.07
493.60%
1.82
64.17%
3.01
65.40%
9.62
220.07%
7.10
26.24%
10.21
43.89%
1.12
89.04%
46.21
4,026.45%
87.12
88.54%
49.59
43.08%
interest debt per share
0.33
-
0.53
58.51%
0.49
7.60%
0.17
65.27%
0.11
33.40%
0.13
18.37%
0.22
64.74%
0.26
18.17%
0.17
34.14%
0.22
25.11%
0.26
23.01%
inventory turnover
2.36
-
1.92
18.91%
2.72
42.20%
3.05
12.00%
3.32
8.93%
4.43
33.21%
3.50
20.97%
6.75
92.83%
6.28
6.89%
3.59
42.86%
1.56
56.47%
invested capital
0.59
-
0.69
16.21%
0.57
17.50%
0.12
79.15%
0.08
29.68%
0.11
26.80%
0.17
56.38%
0.19
16.53%
0.10
49.94%
0.10
1.24%
0.12
22.12%
market cap
6.44B
-
9.44B
46.56%
23.06B
144.20%
18.49B
19.82%
17.51B
5.30%
14.61B
16.54%
12.81B
12.32%
12.11B
5.47%
28.77B
137.51%
26.44B
8.09%
20.55B
22.29%
net current asset value
-157.85M
-
-2.60B
1,544.41%
-2.27B
12.52%
1.46B
164.18%
1.75B
19.76%
1.43B
18.29%
460.69M
67.70%
-114.95M
124.95%
1.36B
1,281.69%
5.38B
296.02%
5.61B
4.21%
net debt to ebitda
4.58
-
2.69
41.38%
3.99
48.72%
1.08
72.89%
0.07
93.55%
-0.15
309.97%
0.97
763.62%
1.77
81.52%
-0.08
104.44%
-0.50
539.49%
-0.32
37.28%
net income per share
0.01
-
0.10
885.71%
0.03
69.57%
0.04
25.71%
0.06
50.00%
0.04
33.33%
0.06
49.25%
0.00
99.43%
0.36
104,961.45%
0.44
22.14%
0.15
66.32%
operating cash flow per share
-0.07
-
0.03
147.49%
0.06
87.06%
0.07
21.51%
0.02
71.67%
0.10
407.17%
0.02
81.91%
0.04
129.79%
0.38
776.27%
0.30
19.77%
0.02
92.42%
payables turnover
4.89
-
2.16
55.96%
2.85
32.02%
3.93
38.16%
5.07
28.96%
6.30
24.30%
4.75
24.67%
4.10
13.61%
4.96
20.86%
3.97
19.92%
4.46
12.25%
receivables turnover
1.25
-
3.29
162.87%
3.30
0.08%
3.57
8.31%
2.86
19.86%
5.74
100.53%
4.53
21.03%
2.88
36.54%
5.47
90.19%
4.68
14.44%
3.99
14.80%
research and ddevelopement to revenue
0.00
-
0.01
443.92%
0.01
1.38%
0.01
29.36%
0.01
23.80%
0.01
17.54%
0.00
55.23%
0.01
54.32%
0.00
48.40%
return on tangible assets
0.01
-
0.10
614.77%
0.03
71.35%
0.03
11.21%
0.05
60.70%
0.03
31.82%
0.04
33.99%
0.00
99.45%
0.22
87,292.31%
0.19
11.95%
0.06
70.17%
revenue per share
0.26
-
0.34
28.95%
0.38
11.63%
0.44
14.77%
0.55
26.03%
0.66
20.53%
0.69
4.15%
0.62
10.55%
1.17
89.64%
1.50
28.18%
1.01
32.90%
roe
0.02
-
0.14
621.79%
0.04
73.01%
0.03
20.33%
0.05
54.98%
0.03
29.75%
0.05
39.04%
0.00
99.43%
0.21
81,171.22%
0.20
6.18%
0.07
67.08%
roic
0.01
-
0.08
581.55%
0.02
77.56%
0.03
34.38%
0.04
68.27%
0.02
42.30%
0.04
57.82%
0.00
96.70%
0.19
15,147.44%
0.18
6.39%
0.05
70.46%
sales general and administrative to revenue
0.01
-
0.01
16.48%
0.01
7.26%
0.02
43.76%
0.02
8.62%
0.01
9.92%
0.01
28.89%
0.02
55.79%
0.01
57.29%
0.01
15.25%
shareholders equity per share
0.54
-
0.74
36.56%
0.83
12.78%
1.32
57.79%
1.27
3.21%
1.21
5.11%
1.30
7.34%
1.31
0.67%
1.69
29.27%
2.20
30.18%
2.25
2.29%
stock based compensation to revenue
-0.49
-
tangible asset value
2.50B
-
2.61B
4.34%
4.09B
57.02%
8.22B
100.92%
8.68B
5.56%
8.73B
0.58%
8.46B
3.07%
8.38B
0.90%
10.77B
28.40%
15.75B
46.34%
18.46B
17.15%
tangible book value per share
0.41
-
0.41
1.34%
0.54
33.83%
1.03
90.64%
1.01
2.77%
0.96
4.42%
0.98
1.63%
0.98
0.59%
1.28
29.82%
1.81
41.94%
2.12
17.03%
working capital
647.89M
-
-1.57B
341.80%
-1.38B
12.14%
2.28B
265.50%
2.26B
0.74%
1.75B
22.42%
706.80M
59.71%
165.62M
76.57%
1.52B
817.95%
5.98B
293.64%
6.18B
3.34%

All numbers in (except ratios and percentages)